Literature DB >> 17683488

Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease.

Fiorella Piemonte1, Stefania Petrini, Laura Maria Gaeta, Giulia Tozzi, Enrico Bertini, Rita Devito, Renata Boldrini, Matilde Marcellini, Enzo Ciacco, Valerio Nobili.   

Abstract

BACKGROUND AND AIM: Oxidative stress is an important pathophysiological mechanism in non-alcoholic steatohepatitis, where hepatocyte apoptosis is significantly increased correlating with disease severity. Protein glutathionylation occurs as a response to oxidative stress, where an increased concentration of oxidized glutathione modifies post-translational proteins by thiol disulfide exchange. In this study, we analyzed the protein glutathionylation in non-alcoholic fatty liver disease (NAFLD) and evaluated a potential association between glutathionylation, fibrosis, and vitamin E treatment.
METHODS: Protein glutathionylation was studied in the livers of 36 children (mean age 12.5 years, range 4-16 years) subdivided into three groups according to their NAFLD activity score (NAS) by Western blot analysis and immunohistochemistry, using a specific monoclonal antibody. In addition, we identified the hepatocyte ultrastructures involved in glutathionylation by immunogold electron microscopy.
RESULTS: Our findings showed that protein glutathionylation increases in the livers of patients with NAFLD and it is correlated with steatohepatitis and liver fibrosis. Its increase appears mainly in nuclei and cytosol of hepatocytes, and it is reversed by antioxidant therapy with reduced fibrosis.
CONCLUSION: Protein glutathionylation significantly increases in livers with NAFLD, strongly suggesting that oxidative injury plays a crucial role in this disease. Furthermore, the marked increase of protein glutathionylation, in correlation with collagen VI immunoreactivity, suggests a link between the redox status of hepatic protein thiols and fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683488     DOI: 10.1111/j.1440-1746.2007.05070.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

Review 1.  Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.

Authors:  Pierluigi Marzuillo; Anna Grandone; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

2.  Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development.

Authors:  Efstathios Vassiliadis; Natasha Barascuk; Morten A Karsdal
Journal:  Am J Transl Res       Date:  2013-01-21       Impact factor: 4.060

3.  Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1.

Authors:  Di Shao; Jingyan Han; Xiuyun Hou; Jessica Fry; Jessica B Behring; Francesca Seta; Michelle T Long; Hemant K Roy; Richard A Cohen; Reiko Matsui; Markus M Bachschmid
Journal:  Antioxid Redox Signal       Date:  2017-02-16       Impact factor: 8.401

4.  Protein glutathionylation in cellular compartments: a constitutive redox signal.

Authors:  Stefania Petrini; Chiara Passarelli; Anna Pastore; Giulia Tozzi; Marianna Coccetti; Manuela Colucci; Marzia Bianchi; Rosalba Carrozzo; Enrico Bertini; Fiorella Piemonte
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

5.  High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes.

Authors:  S S Loza-Medrano; L A Baiza-Gutman; L Manuel-Apolinar; R García-Macedo; L Damasio-Santana; O A Martínez-Mar; M C Sánchez-Becerra; M Cruz-López; M A Ibáñez-Hernández; M Díaz-Flores
Journal:  Mol Biol Rep       Date:  2019-10-24       Impact factor: 2.316

6.  In situ analysis of protein S-glutathionylation in lung tissue using glutaredoxin-1-catalyzed cysteine derivatization.

Authors:  Scott W Aesif; Vikas Anathy; Marije Havermans; Amy S Guala; Karina Ckless; Douglas J Taatjes; Yvonne M W Janssen-Heininger
Journal:  Am J Pathol       Date:  2009-07       Impact factor: 4.307

7.  Glutathione disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease.

Authors:  Xiaobing Dou; Songtao Li; Linfeng Hu; Lei Ding; Yue Ma; Wang Ma; Hui Chai; Zhenyuan Song
Journal:  Exp Mol Med       Date:  2018-04-06       Impact factor: 8.718

8.  Differential representation of liver proteins in obese human subjects suggests novel biomarkers and promising targets for drug development in obesity.

Authors:  Simonetta Caira; Antonio Iannelli; Rosaria Sciarrillo; Gianluca Picariello; Giovanni Renzone; Andrea Scaloni; Pietro Addeo
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 9.  Role of Glutaredoxin-1 and Glutathionylation in Cardiovascular Diseases.

Authors:  Mannix Burns; Syed Husain Mustafa Rizvi; Yuko Tsukahara; David R Pimentel; Ivan Luptak; Naomi M Hamburg; Reiko Matsui; Markus M Bachschmid
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

10.  Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease.

Authors:  Hye Ran Yang
Journal:  Korean J Pediatr       Date:  2013-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.